ecogacrinnews2

January 26, 2022

Come Again? Communicating Clearly About Risk of Recurrence After Early-Stage Breast Cancer

Mary Lou Smith and colleagues at the Research Advocacy Network recently explored how well patients with early-stage breast cancer understand risk of recurrence
January 26, 2022

Trial Spotlight: Jarushka Naidoo on the EAQ172 Trial for Steroid-Refractory Pneumonitis

This randomized phase II trial aims to establish which agent, infliximab versus intravenous immunoglobulin, may lead to greatest benefit as pneumonitis treatment for patients receiving PD-1/PD-L1 therapy
December 22, 2021
Lung x-ray on iPad

Trial Spotlight: Helena Yu on the EA5182 Trial for Metastatic, EGFR-Mutant Non-Small Cell Lung Cancer

This trial aims to help define the optimal first-line treatment for patients with advanced, EGFR-mutant NSCLC and elucidate mechanisms of resistance to therapy
October 19, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, October 2021

A focus on the Fall 2021 ECOG-ACRIN Group Meeting; remembering two major leaders in oncology; studying smoking cessation in patients with cancer
October 19, 2021

Virtual Fall 2021 Group Meeting: Tips and Highlights

Though we had hoped to meet in person this fall, the pandemic has kept us on our toes—and in front of our screens.
October 19, 2021
Young investigator headshots

Meet the 2021 Young Investigator Symposium Presenters

Eight early-career investigators will present their work; two will be selected to receive awards of distinction
October 19, 2021

Remembering Martin “Mac” Cheever, MD

In September, the field of immunotherapy lost one of its pioneers
October 19, 2021

Remembering Franco M. Muggia, MD

In September, the field of oncology lost a worldwide ovarian therapeutics leader and unparalleled mentor to generations
October 19, 2021
Man on couch on laptop

Trial Spotlight: Elyse Park on EAQ171CD – the Smoke-Free Support Study 2.0

This phase II randomized controlled trial is comparing the effectiveness of two different approaches to help recently diagnosed patients with cancer become smoke-free
October 19, 2021
News in Brief

News in Brief, October 2021

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
September 30, 2021

Now Enrolling: Phase II of EA9152 for Acute Lymphoblastic Leukemia

This phase Ib/II study is testing the effects and safety of venetoclax in combination with liposomal vincristinein patients with B-ALL or T-ALL
September 30, 2021
News in Brief

News in Brief, September 2021

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more